8-1771069-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_018941.4(CLN8):c.15C>T(p.Ser5Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )
Consequence
CLN8
NM_018941.4 synonymous
NM_018941.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.911
Publications
0 publications found
Genes affected
CLN8 (HGNC:2079): (CLN8 transmembrane ER and ERGIC protein) This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
CLN8 Gene-Disease associations (from GenCC):
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 8Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Orphanet, Ambry Genetics, Myriad Women’s Health
- neuronal ceroid lipofuscinosis 8 northern epilepsy variantInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- autism spectrum disorderInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 8-1771069-C-T is Benign according to our data. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-1771069-C-T is described in CliVar as Likely_benign. Clinvar id is 377698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.911 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN8 | NM_018941.4 | c.15C>T | p.Ser5Ser | synonymous_variant | Exon 2 of 3 | ENST00000331222.6 | NP_061764.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLN8 | ENST00000331222.6 | c.15C>T | p.Ser5Ser | synonymous_variant | Exon 2 of 3 | 1 | NM_018941.4 | ENSP00000328182.4 | ||
KBTBD11-OT1 | ENST00000635855.1 | n.15C>T | non_coding_transcript_exon_variant | Exon 2 of 30 | 5 | ENSP00000489726.1 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152002Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251476 AF XY: 0.0000294 show subpopulations
GnomAD2 exomes
AF:
AC:
12
AN:
251476
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461834Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 41AN XY: 727214 show subpopulations
GnomAD4 exome
AF:
AC:
96
AN:
1461834
Hom.:
Cov.:
32
AF XY:
AC XY:
41
AN XY:
727214
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33480
American (AMR)
AF:
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53382
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
88
AN:
1111990
Other (OTH)
AF:
AC:
4
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152002Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74222 show subpopulations
GnomAD4 genome
AF:
AC:
11
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74222
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41398
American (AMR)
AF:
AC:
1
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5148
South Asian (SAS)
AF:
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68014
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 03, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuronal ceroid lipofuscinosis Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.